About 7,000 searches a month ask whether creatine helps muscles recover — most of them some version of "creatine supplements for muscle recovery". The question has been tested more than most creatine claims: at least three meta-analyses have pooled the trials. They disagree with each other, and the way they disagree is more useful than any single headline. What follows reports what the trials measured — no advice on whether anyone should take creatine for this (how we work).
What "recovery" means in these trials
Recovery studies follow a standard pattern. Volunteers take creatine or a placebo for some days, then do a bout of exercise designed to damage muscle — usually slow eccentric (lengthening) contractions of the arm or thigh, or high-volume squats — and are measured for up to a week afterwards. Four kinds of outcome come up again and again:
- Function — maximal strength and range of motion. This is the closest thing to recovery in the everyday sense.
- Soreness — rated on a scale, often while pressing on the muscle.
- Blood markers — creatine kinase (CK), lactate dehydrogenase (LDH) and myoglobin, proteins that leak out of damaged muscle cells. Our page on creatine in bloodwork explains why CK is not the same thing as creatine or creatinine.
- Inflammation and oxidative stress — C-reactive protein, interleukins and similar.
A lower CK reading is a sign of less leakage. It is not, on its own, evidence that strength comes back sooner. That distinction runs through every result below.
Three meta-analyses, three readings
| Review | Trials pooled | People | Headline finding |
|---|---|---|---|
| Northeast & Clifford, Int J Sport Nutr Exerc Metab 2021 | 13 | 278 | No effect on strength, soreness, range of motion or inflammation at any of five time points (to 96 h). CK lower at 48 h only. |
| Jiaming & Rahimi, J Food Biochem 2021 | 9 | not stated in abstract | CK about 31 U/L lower overall; LDH not significantly lower overall. High heterogeneity, medium risk of bias. |
| Doma et al., Sports Medicine 2022 | 23 | 469 | Damage markers lower at 48–90 h after a single bout; higher at 24 h when the bout followed weeks of supplemented training. Soreness and inflammation differences not significant. |
Sources: Northeast & Clifford 2021, PMID 33631721 · Jiaming & Rahimi 2021, PMID 34472118 · Doma et al. 2022, PMID 35218552. All three abstracts read 2026-10-11.
The Loughborough review is the most cautious: its conclusion is that creatine "does not accelerate recovery following exercise-induced muscle damage". The 2021 Chinese–Iranian review reads a similar CK signal as a benefit and recommends creatine, while warning in the same paragraph about heterogeneity and bias. The James Cook University review found something neither of the others looked for — a reversal. After one hard session, the creatine groups leaked less. After the last session of several weeks of training on creatine, they leaked more at 24 hours. The authors call it "paradoxical" and do not claim to know whether the extra damage is harmful or part of how creatine helps people train harder.
Every one of the three reports high heterogeneity: the trials vary in exercise, duration of creatine use and timing of measurement so much that a single pooled number hides more than it shows.
The trials one by one
We ran a PubMed query on 2026-10-11 — creatine in the title, supplementation, muscle damage or soreness or DOMS, limited to randomised controlled trials — and read the abstracts. Ten were human trials of exercise-induced damage.
| Trial | Who | Creatine before the test | Result |
|---|---|---|---|
| Rawson et al. 2001, J Strength Cond Res | 23 men | 20 g/day for 5 days | No difference in any marker after 50 maximal eccentric contractions |
| Rawson et al. 2007, J Strength Cond Res | 22 trained men | 5 days (10 in total) | No difference in strength, soreness, CK, LDH or CRP after high-volume squats |
| Boychuk et al. 2016, Muscle Nerve | 14 men | 0.3 g/kg/day, before and during recovery | No difference in strength, activation or damage indicators |
| Bassit et al. 2010, Eur J Appl Physiol | 8 athletes (4 per group), plus rats | 5 days | Lower CK, LDH and aldolase after a competition |
| Veggi et al. 2013, Int J Sport Nutr Exerc Metab | 18 young men | 6 days, then 2 g/day, across two bouts 14 days apart | Smaller marker rise after the second bout |
| Wang et al. 2018, Nutrients | explosive-sport athletes | 4 weeks with training | Lower CK after the training bout; greater strength |
| Yamaguchi et al. 2024, Nutrients | 20 men | 28 days | Faster strength return, less arm swelling |
| Yamaguchi et al. 2025, Nutrients | 40 men and women | 33 days | Faster strength return; less swelling in the women |
| Salem et al. 2025, J Int Soc Sports Nutr | 10 trained men (crossover) | 3 days | Less soreness before the second session |
| Ben Maaoui et al. 2025, Nutrients | physically active men | 20 g/day for 7 days | Less soreness; recovery markers to 72 h unchanged |
PubMed IDs, in table order: 11710402, 18076246, 26930603, 19956970, 23349298, 30400221, 38542807, 40507040, 41579075, 41470776.
Seven of the ten report a benefit on at least one marker; three report none. There is no clean dividing line between them. The three null trials all tested a single session of maximal eccentric work or punishing squats after a short course of creatine — but so did some of the positive ones (both Yamaguchi trials used eccentric elbow work). The positive list is also where the small samples sit: four athletes per group, ten men in a crossover. And a "benefit" ranges from strength returning sooner (two trials) to lower blood markers with no measured change in function (several) to less soreness with recovery markers unchanged (one).
Funding is stated where it matters. Both Yamaguchi trials (2024 and 2025) declare funding from Taisho Pharmaceutical, and the 2025 paper says the company collaborated on the study while having no role in design, analysis or publication. The 2025 crossover trial analysed ten men. The 2010 competition study had four athletes per group. None of that makes the findings wrong; it is why the pooled analyses matter more than any one of them.
What recovery evidence does not show
Two common claims run ahead of the trials:
- "Creatine speeds recovery so you can train again sooner." No trial has measured the time until someone can repeat a training session at full output as its main outcome. The closest is maximal voluntary contraction over the following days, and the largest pooled analysis found no difference.
- "Creatine reduces soreness." Individual trials report it; the 2021 pooled analysis did not find it at any time point, and the 2022 one found a difference that did not reach significance.
What the trials do support more consistently is outside the recovery question altogether: more repeated high-intensity work and, over weeks of training, more strength and lean mass (creatine for muscle growth and the benefits that are graded strong cover those). Sleep loss is a separate thread — the trials in sleep-deprived people are on creatine and sleep.
Injury, casts and rehabilitation
Searchers also ask about "creatine for injury recovery" (about 160 a month). The trials here are about muscle lost to disuse or surgery, and they split:
- After ACL reconstruction, 60 patients were randomised to creatine or placebo through 12 weeks of rehabilitation. Strength and power came back by the same amounts in both groups, and hop distance and knee scores at six months did not differ (Tyler et al., Am J Sports Med 2004, PMID 14977662).
- An arm in a cast for a week: seven creatine-naïve men, single-blind crossover, 20 g a day. Creatine preserved more lean mass (+0.9% vs −3.7%) and elbow-flexor strength (−4.1% vs −21.5%) (Johnston et al., J Strength Cond Res 2009, PMID 19130643).
- A leg in a cast for a week: 30 young men loaded 20 g a day for five days beforehand. Creatine did not preserve muscle mass or strength (Backx et al., Sports Medicine 2017, PMID 28054322) — the larger, double-blind, biopsied trial of the two.
- Patellar tendinopathy: 20 athletes on an eight-week rehabilitation programme, with creatine or sucrose after each eccentric session. Both groups improved by similar amounts at eight weeks; only the creatine group showed a significant improvement in its pain-and-function score (VISA-P) at four weeks (Sánchez-Gómez et al., J Int Soc Sports Nutr 2026, PMID 42730713).
That is four settings, four sample sizes and no consensus. For anyone recovering from an injury, the creatine question belongs with the clinician or physiotherapist running the rehabilitation. The tendon and ligament peptide claims that circulate in the same searches are on peptides for recovery, and the collagen trials that targeted tendons and muscle soreness are on collagen peptides for muscle recovery.
What would settle it
The open questions are specific. Does weeks of creatine reduce damage after one bout but increase it during training, as the 2022 analysis suggests — and if so, does that matter for adaptation? Do women respond differently (the 2025 Japanese trial saw less swelling only in women, in a small subgroup)? And does any change in CK translate into strength returning sooner? A trial powered for strength recovery as its primary outcome, without industry funding, would answer more than another CK study.
What this page cannot tell you
- It reports abstracts and the three pooled analyses; it did not re-pool the data.
- "Recovery" in these trials is a damage-and-function test over a few days. Recovery across a training block, fatigue, or sleep are different questions.
- Nothing here suggests an amount, a schedule or a reason to take creatine. Anyone with an injury, a kidney condition or a medication question should ask a clinician.
Sources
- Northeast B, Clifford T. The effect of creatine supplementation on markers of exercise-induced muscle damage: a systematic review and meta-analysis of human intervention trials. Int J Sport Nutr Exerc Metab 2021;31(3):276–91 — PMID 33631721
- Jiaming Y, Rahimi MH. Creatine supplementation effect on recovery following exercise-induced muscle damage: a systematic review and meta-analysis of randomized controlled trials. J Food Biochem 2021;45(10):e13916 — PMID 34472118
- Doma K, Ramachandran AK, Boullosa D, Connor J. The paradoxical effect of creatine monohydrate on muscle damage markers: a systematic review and meta-analysis. Sports Med 2022;52(7):1623–45 — PMID 35218552
- Tyler TF, Nicholas SJ, Hershman EB, et al. The effect of creatine supplementation on strength recovery after anterior cruciate ligament (ACL) reconstruction. Am J Sports Med 2004;32(2):383–8 — PMID 14977662
- Johnston AP, Burke DG, MacNeil LG, Candow DG. Effect of creatine supplementation during cast-induced immobilization on the preservation of muscle mass, strength, and endurance. J Strength Cond Res 2009;23(1):116–20 — PMID 19130643
- Backx EMP, Hangelbroek R, Snijders T, et al. Creatine loading does not preserve muscle mass or strength during leg immobilization in healthy, young males. Sports Med 2017;47(8):1661–71 — PMID 28054322
- Sánchez-Gómez Á, Malaguti M, Sañudo B, et al. Could creatine supplementation combined with physical rehabilitation accelerate return to play in athletes with patellar tendinopathy? J Int Soc Sports Nutr 2026 — PMID 42730713
- The ten muscle-damage trials in the table, by the PubMed IDs listed beneath it. PubMed query run and abstracts read on 2026-10-11.